WallachBeth Capital, LLC
Harborside Financial Plaza 5
185 Hudson St., Suite 1410
Jersey City, NJ 07311
August 10, 2022
VIA EDGAR CORRESPONDENCE
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ms. Taylor Beech, Staff Attorney
| Re: | bioAffinity Technologies, Inc. |
| Registration Statement on Form S-1 | |
| File No. 333-264463 | |
| WITHDRAWAL OF REQUEST FOR ACCELERATION OF EFFECTIVENESS |
Dear Ms. Beech:
Reference is made to our letter, filed as correspondence via EDGAR on August 10, 2022, in which we requested the acceleration of the effective date of the above-referenced Registration Statement on Form S-1 for 4:30 p.m., Eastern Time, on Wednesday, August 10, 2022, in accordance with Rule 461 under the Securities Act of 1933, as amended.
We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of that effective date.
Please contact our counsel, Jeffrey Koeppel, Esq., of Carmel, Milazzo & Feil LLP, at (301) 785-4319 if you have any questions in this regard.
| Best Regards, | ||
| WALLACHBETH CAPITAL, LLC | ||
| By: | /s/ Eric Schweitzer | |
| Name: | Eric Schweitzer | |
| Title: | Chief Compliance Officer | |